341 related articles for article (PubMed ID: 6450244)
1. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
Weiss A; MacDonald HR; Cerottini JC; Brunner KT
J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
[TBL] [Abstract][Full Text] [Related]
2. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
[TBL] [Abstract][Full Text] [Related]
3. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
[TBL] [Abstract][Full Text] [Related]
4. Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens.
Weiss A; Brunner KT; MacDonald HR; Cerottini JC
J Exp Med; 1980 Nov; 152(5):1210-25. PubMed ID: 6159445
[TBL] [Abstract][Full Text] [Related]
5. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
Azuma H; Phillips JD; Green WR
J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
[TBL] [Abstract][Full Text] [Related]
6. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
7. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
Davignon JL; Guimezanes A; Schmitt-Verhulst AM
J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
[TBL] [Abstract][Full Text] [Related]
8. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
Pircher H; Hämmerling G; Hengartner H
Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
[TBL] [Abstract][Full Text] [Related]
9. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
11. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level.
MacDonald HR; Thiernesse N; Cerottini JC
J Immunol; 1981 May; 126(5):1671-5. PubMed ID: 6452474
[TBL] [Abstract][Full Text] [Related]
13. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
14. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
15. Frequency and cross-reactivity od cytolytic T lymphocyte precursors reacting against male alloantigens.
Kanagawa O; Louis J; Cerottini JC
J Immunol; 1982 May; 128(5):2362-6. PubMed ID: 6174631
[TBL] [Abstract][Full Text] [Related]
16. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
Green WR
Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
[TBL] [Abstract][Full Text] [Related]
17. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
18. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H
J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558
[TBL] [Abstract][Full Text] [Related]
19. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
20. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
